| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.04 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |